Innoviva, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Innoviva, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Innoviva, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $3.24M.
  • Innoviva, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $4.4M, a 82.4% decline from 2022.
  • Innoviva, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $25M, a 67.3% decline from 2021.
  • Innoviva, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $76.4M, a 26.5% increase from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.4M -$20.6M -82.4% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-03-05
2022 $25M -$51.4M -67.3% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-03-05
2021 $76.4M +$16M +26.5% Jan 1, 2021 Dec 31, 2021 10-K/A 2024-03-05
2020 $60.4M +$18.5M +44.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $41.9M +$238M Jan 1, 2019 Dec 31, 2019 10-K/A 2022-03-17
2018 -$196M -$196M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.